News
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Globus Medical is gearing up for a series of product launches throughout the Musculoskeletal portfolio in the coming months of 2025.
NuVasive infringed five patents from a spine surgeon, a jury determined, according to an April 22 report from Bloomberg Law. The jury ruled that screw assemblies from the Reline, Armada and VuePoint ...
We estimate the company's R&D expense to increase 11.2% in 2025. Globus Medical has merged its business with NuVasive. The combined global musculoskeletal company is focused on rapid innovation ...
Hosted on MSN26d
Expanding Global Market, NuVasive Benefits to Aid GMED StockThe stock carries a Zacks Rank #2 (Buy) currently. Globus Medical merged its business with NuVasive. The combined company has formed a global musculoskeletal company focused on rapid innovation ...
Hosted on MSN15d
Should You Hold Globus Medical Stock in Your Portfolio Now?Globus Medical, Inc. GMED continues to benefit from the robust demand for its Musculoskeletal Solutions products. Following the NuVasive merger, the combined company has formed a global ...
After 5 amazing years at NuVasive/Globus Medical, I'm excited to start a new chapter and continue driving innovation in additive manufacturing. I'm passionate about the value of AM and I'm eager ...
The websites of the top 10 trauma and orthopaedic manufacturers by market capitalisation will be searched: currently, Johnson & Johnson, Zimmer Biomet, Stryker, Medtronic, Smith & Nephew, Arthrex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results